Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine
References (33)
- et al.
Identification of the paraisomer of tyramine in rat brain
Life Sci.
(1973) - et al.
Brain 2-phenylethylamine as a major mediator for the central actions of amphetamine and methylphenidate
Life Sci.
(1975) Amines and theories in psychiatry
The Lancet
(1974)- et al.
False neurotransmitters and hepatic failure
The Lancet
(1971) - et al.
GABA and glutamate uptake by subcellular fractions enriched in synaptosomes: critical evaluation of some methodological aspects
Brain Res.
(1973) - et al.
A simple apparatus for studying the release of neurotransmitters from synaptosomes
European J. Pharmacol.
(1974) - et al.
d-Amphetamine and the release of 3H-norepinephrine from synaptosomes
European J. Pharmacol.
(1974) - et al.
d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes
European J. Pharmacol.
(1975) - et al.
Uptake and subcellular localization of neurotransmitters in the brain
Intern. Rev. Neurobiol.
(1970) - et al.
Octopamine, phenylethanolamine, phenylethylamine and tryptamine in the brain
Ciba Found. Symp.
(1974)
Interaction of β-phenylethylamine with dopamine and noradrenaline in the central nervous system of the rat
J. Pharm. Pharmacol.
(1976)
Compounds antagonistic to norepinephrine retention by rat brain homogenates
Biochem. Pharmacol.
(1971)
The uptake and subcellular distribution of aromatic amines in the brain of the rat
J. Neurochem.
(1971)
The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart
Brit. J. Pharmacol. Chemotherap.
(1965)
Identification and distribution of β-phenylethylamine in the rat
Can. J. Biochem.
(1973)
The isolation of nerve endings from brain: an electron microscope study of cell fragments derived by homogenization and centrifugation
J. Anat. (London)
(1962)
Cited by (198)
TAAR1 as an emerging target for the treatment of psychiatric disorders
2024, Pharmacology and TherapeuticsModafinil, an atypical CNS stimulant?
2024, Advances in PharmacologyPharmacogenomics of drugs of abuse
2019, Critical Issues in Alcohol and Drugs of Abuse TestingThe role of human dopamine transporter in NeuroAIDS
2018, Pharmacology and TherapeuticsSadA-Expressing Staphylococci in the Human Gut Show Increased Cell Adherence and Internalization
2018, Cell ReportsCitation Excerpt :However, these reactions may also occur by the gut microflora. Not only the classical neurotransmitters, but TAs as well can exert pronounced pharmacological effects in many species; they can affect uptake or release of catecholamines or serotonin activity at nerve endings (Raiteri et al., 1977), and they might also act as neuromodulators through direct actions on receptors for catecholamines or serotonin (Jones, 1982; Paterson and Boulton, 1988). TAs are attracting attention as neurotransmitters because they are believed to play a role in human disorders (Branchek and Blackburn, 2003; Martinucci et al., 2015).
Methods of Trace Amine Analysis in Mammalian Brain
2016, Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors
Copyright © 1977 Published by Elsevier B.V.